CagriSema 10MG/10MG

Description

Description

Components:

• Cagrilintide: 10mg

• Semaglutide: 10mg
  CAS Numbers:

• Cagrilintide: 2133459-98-0

• Semaglutide: 910463-68-2
  Molecular Weights:

• Cagrilintide: ~7342.5 g/mol

• Semaglutide: ~4113.6 g/mol
  Form: Lyophilized Powder
  Quantity: 20mg total (10mg Cagrilintide + 10mg Semaglutide)
  Purity: ≥ 98% (HPLC Verified)

Product Overview:

CagriSema is a research peptide blend that combines two powerful metabolic modulators: Cagrilintide, a long-acting amylin analog, and Semaglutide, a GLP-1 receptor agonist. This combination has been studied in advanced metabolic models for its synergistic effects on appetite suppression, gastric emptying delay, caloric intake reduction, and body weight regulation.

By simultaneously targeting amylin receptors (Cagrilintide) and GLP-1 receptors (Semaglutide), CagriSema has demonstrated enhanced potential in preclinical research when compared to either agent alone.

Key areas of research include:

• Obesity and metabolic disease modeling

• Dual-hormone synergy in appetite and satiety signaling

• Gastric motility and energy intake regulation

• Investigations into multi-receptor agonist therapy strategies

Applications in Research:

• Appetite suppression and food intake studies

• Weight loss protocols in preclinical metabolic models

• Hormonal crosstalk and receptor synergy

• Investigations into triple-agonist development and metabolic pathway integration

Storage & Handling:

Store lyophilized blend at -20°C, protected from light and moisture.
Reconstitute with sterile bacteriostatic water for laboratory use. Once reconstituted, store refrigerated and use within research-appropriate timelines. Avoid repeated freeze-thaw cycles.

⚠️ Research Use Only – Legal Disclaimer

All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.

Simple Peptide is a chemical supplier. Simple Peptide is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Simple Peptide is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.

All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.